| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | transcription coactivator activity | 9.21e-05 | 303 | 94 | 8 | GO:0003713 | |
| GeneOntologyBiologicalProcess | nuclear receptor-mediated signaling pathway | 4.32e-06 | 202 | 95 | 8 | GO:0141193 | |
| GeneOntologyBiologicalProcess | branching morphogenesis of an epithelial tube | 3.66e-05 | 198 | 95 | 7 | GO:0048754 | |
| GeneOntologyBiologicalProcess | morphogenesis of a branching epithelium | 1.10e-04 | 236 | 95 | 7 | GO:0061138 | |
| GeneOntologyBiologicalProcess | positive regulation of TORC2 signaling | 1.25e-04 | 4 | 95 | 2 | GO:1904515 | |
| GeneOntologyBiologicalProcess | intracellular receptor signaling pathway | 1.29e-04 | 416 | 95 | 9 | GO:0030522 | |
| GeneOntologyBiologicalProcess | estrogen receptor signaling pathway | 1.38e-04 | 57 | 95 | 4 | GO:0030520 | |
| GeneOntologyBiologicalProcess | epithelial tube morphogenesis | 1.41e-04 | 421 | 95 | 9 | GO:0060562 | |
| GeneOntologyBiologicalProcess | cellular response to vitamin D | 1.57e-04 | 23 | 95 | 3 | GO:0071305 | |
| MousePheno | abnormal sensory neuron physiology | 1.96e-06 | 72 | 73 | 6 | MP:0010055 | |
| MousePheno | abnormal somatic nervous system physiology | 4.52e-06 | 83 | 73 | 6 | MP:0005423 | |
| MousePheno | abnormal cochlear hair cell physiology | 5.43e-05 | 40 | 73 | 4 | MP:0004432 | |
| Domain | ANK_REPEAT | ESPN ANKFY1 TRPA1 ANK2 ANKDD1A ANKRD17 ANKHD1 KANK2 ZDHHC13 BANK1 ANKS3 | 5.19e-08 | 253 | 93 | 11 | PS50088 |
| Domain | Ankyrin_rpt-contain_dom | ESPN ANKFY1 TRPA1 ANK2 ANKDD1A ANKRD17 ANKHD1 KANK2 ZDHHC13 BANK1 ANKS3 | 5.41e-08 | 254 | 93 | 11 | IPR020683 |
| Domain | ANK_REP_REGION | ESPN ANKFY1 TRPA1 ANK2 ANKDD1A ANKRD17 ANKHD1 KANK2 ZDHHC13 BANK1 ANKS3 | 5.41e-08 | 254 | 93 | 11 | PS50297 |
| Domain | Ankyrin_rpt | ESPN ANKFY1 TRPA1 ANK2 ANKDD1A ANKRD17 ANKHD1 KANK2 ZDHHC13 BANK1 ANKS3 | 7.41e-08 | 262 | 93 | 11 | IPR002110 |
| Domain | Ank | ESPN ANKFY1 TRPA1 ANK2 ANKDD1A ANKRD17 ANKHD1 KANK2 ZDHHC13 ANKS3 | 2.01e-07 | 228 | 93 | 10 | PF00023 |
| Domain | - | ESPN ANKFY1 TRPA1 ANK2 ANKDD1A ANKRD17 KANK2 ZDHHC13 BANK1 ANKS3 | 4.37e-07 | 248 | 93 | 10 | 1.25.40.20 |
| Domain | ANK | ESPN ANKFY1 TRPA1 ANK2 ANKDD1A ANKRD17 ANKHD1 KANK2 ZDHHC13 ANKS3 | 4.88e-07 | 251 | 93 | 10 | SM00248 |
| Domain | Ank_2 | 1.25e-06 | 215 | 93 | 9 | PF12796 | |
| Domain | BAF250_C | 2.45e-05 | 2 | 93 | 2 | IPR033388 | |
| Domain | BAF250_C | 2.45e-05 | 2 | 93 | 2 | PF12031 | |
| Domain | BAF250/Osa | 2.45e-05 | 2 | 93 | 2 | IPR021906 | |
| Pubmed | ZSWIM8 LIMK2 ARID1B MTA1 CDK2AP1 DROSHA NEURL1 AOX1 ANKRD17 ASCC3 TAF7 ARID1A ANKHD1 KANK2 ZDHHC13 ANKS3 PML | 8.74e-09 | 1116 | 95 | 17 | 31753913 | |
| Pubmed | 1.97e-07 | 5 | 95 | 3 | 20505086 | ||
| Pubmed | 6.86e-07 | 7 | 95 | 3 | 16962269 | ||
| Pubmed | 6.86e-07 | 7 | 95 | 3 | 13853422 | ||
| Pubmed | Interaction network of human early embryonic transcription factors. | 5.63e-06 | 351 | 95 | 8 | 38297188 | |
| Pubmed | Chemoproteomics profiling of HDAC inhibitors reveals selective targeting of HDAC complexes. | 7.14e-06 | 45 | 95 | 4 | 21258344 | |
| Pubmed | 7.38e-06 | 2 | 95 | 2 | 30718275 | ||
| Pubmed | Dissecting the role of SWI/SNF component ARID1B in steady-state hematopoiesis. | 7.38e-06 | 2 | 95 | 2 | 37611161 | |
| Pubmed | 7.38e-06 | 2 | 95 | 2 | 32791957 | ||
| Pubmed | A novel type of myosin encoded by the mouse deafness gene shaker-2. | 7.38e-06 | 2 | 95 | 2 | 9703981 | |
| Pubmed | Chromatin accessibility underlies synthetic lethality of SWI/SNF subunits in ARID1A-mutant cancers. | 7.38e-06 | 2 | 95 | 2 | 28967863 | |
| Pubmed | 7.38e-06 | 2 | 95 | 2 | 34386776 | ||
| Pubmed | 7.38e-06 | 2 | 95 | 2 | 23202128 | ||
| Pubmed | 7.38e-06 | 2 | 95 | 2 | 33890484 | ||
| Pubmed | 7.38e-06 | 2 | 95 | 2 | 22153079 | ||
| Pubmed | ARID1B is a specific vulnerability in ARID1A-mutant cancers. | 7.38e-06 | 2 | 95 | 2 | 24562383 | |
| Pubmed | ARID1B as a Potential Therapeutic Target for ARID1A-Mutant Ovarian Clear Cell Carcinoma. | 7.38e-06 | 2 | 95 | 2 | 29890703 | |
| Pubmed | 7.38e-06 | 2 | 95 | 2 | 24788099 | ||
| Pubmed | 7.38e-06 | 2 | 95 | 2 | 33052929 | ||
| Pubmed | Concurrent ARID1A and ARID1B inactivation in endometrial and ovarian dedifferentiated carcinomas. | 7.38e-06 | 2 | 95 | 2 | 27562491 | |
| Pubmed | 9.25e-06 | 268 | 95 | 7 | 33640491 | ||
| Pubmed | 9.69e-06 | 103 | 95 | 5 | 10574462 | ||
| Pubmed | CSDE1 ZSWIM8 SF3B4 MTA1 ANK2 DROSHA USP9X EIF4G2 ZNF521 FTCD PBX1 ARID1A NEUROD6 KANK2 | 1.03e-05 | 1285 | 95 | 14 | 35914814 | |
| Pubmed | An inducible CRISPR/Cas9 screen identifies DTX2 as a transcriptional regulator of human telomerase. | 1.05e-05 | 180 | 95 | 6 | 35198878 | |
| Pubmed | CSDE1 PRR12 TOMM70 SHROOM3 MTA1 CDK2AP1 ZNF277 DROSHA EIF4G2 NFX1 ANKRD17 ASCC3 MED1 ANKHD1 KANK2 | 1.30e-05 | 1497 | 95 | 15 | 31527615 | |
| Pubmed | The functional interactome landscape of the human histone deacetylase family. | 1.51e-05 | 289 | 95 | 7 | 23752268 | |
| Pubmed | 2.21e-05 | 3 | 95 | 2 | 21647563 | ||
| Pubmed | Genetic analyses of the mouse deafness mutations varitint-waddler (Va) and jerker (Espnje). | 2.21e-05 | 3 | 95 | 2 | 12209292 | |
| Pubmed | 2.21e-05 | 3 | 95 | 2 | 21865467 | ||
| Pubmed | 2.21e-05 | 3 | 95 | 2 | 34512623 | ||
| Pubmed | 2.21e-05 | 3 | 95 | 2 | 33432679 | ||
| Pubmed | 2.21e-05 | 3 | 95 | 2 | 21461859 | ||
| Pubmed | 2.21e-05 | 3 | 95 | 2 | 37428632 | ||
| Pubmed | 2.21e-05 | 3 | 95 | 2 | 34044070 | ||
| Pubmed | Genome-Wide Transcriptional Regulation Mediated by Biochemically Distinct SWI/SNF Complexes. | 2.21e-05 | 3 | 95 | 2 | 26716708 | |
| Pubmed | Mutations affecting components of the SWI/SNF complex cause Coffin-Siris syndrome. | 2.21e-05 | 3 | 95 | 2 | 22426308 | |
| Pubmed | 2.21e-05 | 3 | 95 | 2 | 24382590 | ||
| Pubmed | Mask family proteins ANKHD1 and ANKRD17 regulate YAP nuclear import and stability. | 2.21e-05 | 3 | 95 | 2 | 31661072 | |
| Pubmed | Conserved expression of ultra-conserved noncoding RNA in mammalian nervous system. | 2.27e-05 | 60 | 95 | 4 | 29055695 | |
| Pubmed | CITED2 FOXD2 HOXC5 ANKFY1 MTA1 OVOL1 NFX1 ZNF521 PBX1 ARID1A | 2.48e-05 | 709 | 95 | 10 | 22988430 | |
| Pubmed | The Functional Proximal Proteome of Oncogenic Ras Includes mTORC2. | PIEZO2 LLGL1 ANK2 DTNB SIGLEC6 NECTIN2 GAL3ST4 SLC39A10 ZDHHC13 | 2.66e-05 | 569 | 95 | 9 | 30639242 |
| Pubmed | An atlas of combinatorial transcriptional regulation in mouse and man. | CSDE1 HOXC5 PAX8 ZNF277 NFX1 MED1 TAF7 PBX1 ZDHHC13 ANKS3 PML | 2.80e-05 | 877 | 95 | 11 | 20211142 |
| Pubmed | Control of stereocilia length during development of hair bundles. | 4.41e-05 | 4 | 95 | 2 | 37011103 | |
| Pubmed | 4.41e-05 | 4 | 95 | 2 | 28453662 | ||
| Pubmed | 4.41e-05 | 4 | 95 | 2 | 18984668 | ||
| Pubmed | TM4SF1 Promotes Metastasis of Pancreatic Cancer via Regulating the Expression of DDR1. | 4.41e-05 | 4 | 95 | 2 | 28368050 | |
| Pubmed | 4.41e-05 | 4 | 95 | 2 | 26522721 | ||
| Pubmed | Cloning and characterization of hELD/OSA1, a novel BRG1 interacting protein. | 4.41e-05 | 4 | 95 | 2 | 11988099 | |
| Pubmed | Gene fusion and overlapping reading frames in the mammalian genes for 4E-BP3 and MASK. | 4.41e-05 | 4 | 95 | 2 | 14557257 | |
| Pubmed | 4.41e-05 | 4 | 95 | 2 | 5955164 | ||
| Pubmed | Cleavage of β-dystroglycan occurs in sarcoglycan-deficient skeletal muscle without MMP-2 and MMP-9. | 4.41e-05 | 4 | 95 | 2 | 28821434 | |
| Pubmed | Protective role of neuronal and lymphoid cannabinoid CB2 receptors in neuropathic pain. | 4.41e-05 | 4 | 95 | 2 | 32687056 | |
| Pubmed | Genetic and physical delineation of the region of the mouse deafness mutation shaker-2. | 4.41e-05 | 4 | 95 | 2 | 9168970 | |
| Pubmed | 4.41e-05 | 4 | 95 | 2 | 28863077 | ||
| Pubmed | 4.41e-05 | 4 | 95 | 2 | 35100259 | ||
| Pubmed | Two related ARID family proteins are alternative subunits of human SWI/SNF complexes. | 4.41e-05 | 4 | 95 | 2 | 15170388 | |
| Pubmed | 6.74e-05 | 497 | 95 | 8 | 23414517 | ||
| Pubmed | 7.34e-05 | 5 | 95 | 2 | 20332152 | ||
| Pubmed | 7.34e-05 | 5 | 95 | 2 | 38489371 | ||
| Pubmed | Recent advances in understanding chromatin remodeling by Swi/Snf complexes. | 7.34e-05 | 5 | 95 | 2 | 12672490 | |
| Pubmed | 7.34e-05 | 5 | 95 | 2 | 12200431 | ||
| Pubmed | SND1 binds SARS-CoV-2 negative-sense RNA and promotes viral RNA synthesis through NSP9. | 7.87e-05 | 258 | 95 | 6 | 37794589 | |
| Pubmed | 8.14e-05 | 83 | 95 | 4 | 28794006 | ||
| Pubmed | An Oct4-centered protein interaction network in embryonic stem cells. | 9.83e-05 | 167 | 95 | 5 | 20362541 | |
| Pubmed | Control of a neuronal morphology program by an RNA-binding zinc finger protein, Unkempt. | 1.03e-04 | 271 | 95 | 6 | 25737280 | |
| Pubmed | 1.10e-04 | 6 | 95 | 2 | 36961815 | ||
| Pubmed | 1.10e-04 | 6 | 95 | 2 | 16230384 | ||
| Pubmed | Numerous BAF complex genes are mutated in Coffin-Siris syndrome. | 1.10e-04 | 6 | 95 | 2 | 25081545 | |
| Pubmed | 1.34e-04 | 549 | 95 | 8 | 38280479 | ||
| Pubmed | TRERF1 PRR12 ARID1B MTA1 PAX8 USP9X GPS2 ZNF521 ANKRD17 PBX1 ARID1A ANKHD1 PML | 1.37e-04 | 1429 | 95 | 13 | 35140242 | |
| Pubmed | 1.41e-04 | 708 | 95 | 9 | 39231216 | ||
| Pubmed | The RNA-binding protein Snd1/Tudor-SN regulates hypoxia-responsive gene expression. | 1.49e-04 | 97 | 95 | 4 | 37151849 | |
| Pubmed | PIEZO2 mediates ultrasonic hearing via cochlear outer hair cells in mice. | 1.54e-04 | 7 | 95 | 2 | 34244441 | |
| Pubmed | 1.54e-04 | 7 | 95 | 2 | 23540691 | ||
| Pubmed | 1.54e-04 | 7 | 95 | 2 | 18270328 | ||
| Pubmed | 1.54e-04 | 7 | 95 | 2 | 21436032 | ||
| Pubmed | A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation. | 1.67e-04 | 724 | 95 | 9 | 36232890 | |
| Pubmed | Reciprocal interaction between SIRT6 and APC/C regulates genomic stability. | 2.10e-04 | 440 | 95 | 7 | 34244565 | |
| Pubmed | 2.23e-04 | 199 | 95 | 5 | 36688959 | ||
| Pubmed | 2.62e-04 | 9 | 95 | 2 | 23556151 | ||
| Pubmed | 2.62e-04 | 9 | 95 | 2 | 37805104 | ||
| Pubmed | TBR1 regulates autism risk genes in the developing neocortex. | 2.62e-04 | 9 | 95 | 2 | 27325115 | |
| Pubmed | Mammalian SWI/SNF--a subunit BAF250/ARID1 is an E3 ubiquitin ligase that targets histone H2B. | 2.62e-04 | 9 | 95 | 2 | 20086098 | |
| Pubmed | 2.62e-04 | 9 | 95 | 2 | 19339464 | ||
| Pubmed | 2.75e-04 | 46 | 95 | 3 | 35022314 | ||
| Pubmed | 2.88e-04 | 615 | 95 | 8 | 31048545 | ||
| Pubmed | 3.03e-04 | 331 | 95 | 6 | 20634891 | ||
| Pubmed | 3.21e-04 | 472 | 95 | 7 | 38943005 | ||
| Pubmed | 3.25e-04 | 216 | 95 | 5 | 31519766 | ||
| Pubmed | 3.28e-04 | 10 | 95 | 2 | 12665591 | ||
| Pubmed | 3.28e-04 | 10 | 95 | 2 | 15922553 | ||
| Pubmed | ARID1a-DNA interactions are required for promoter occupancy by SWI/SNF. | 3.28e-04 | 10 | 95 | 2 | 23129809 | |
| Pubmed | The mRNA-bound proteome and its global occupancy profile on protein-coding transcripts. | 3.70e-04 | 807 | 95 | 9 | 22681889 | |
| Pubmed | 3.74e-04 | 808 | 95 | 9 | 20412781 | ||
| Pubmed | 4.00e-04 | 11 | 95 | 2 | 8223273 | ||
| Pubmed | A biphasic pattern of gene expression during mouse retina development. | 4.00e-04 | 11 | 95 | 2 | 17044933 | |
| Pubmed | Variants in LRRC7 lead to intellectual disability, autism, aggression and abnormal eating behaviors. | 4.00e-04 | 11 | 95 | 2 | 39256359 | |
| Pubmed | 4.16e-04 | 650 | 95 | 8 | 38777146 | ||
| Pubmed | 4.18e-04 | 127 | 95 | 4 | 30442766 | ||
| Pubmed | 4.67e-04 | 55 | 95 | 3 | 35945219 | ||
| GeneFamily | Ankyrin repeat domain containing | ESPN ANKFY1 TRPA1 ANK2 ANKDD1A ANKRD17 ANKHD1 KANK2 ZDHHC13 BANK1 ANKS3 | 1.11e-09 | 242 | 66 | 11 | 403 |
| GeneFamily | AT-rich interaction domain containing | 1.34e-03 | 15 | 66 | 2 | 418 | |
| ToppCell | Epithelial_cells-Epithelial_cells|World / Immune cells in Kidney/Urine in Lupus Nephritis | 2.13e-07 | 198 | 94 | 7 | 52e9d41a1726bc1140df6baec9f17a534448ac8b | |
| ToppCell | Epithelial_cells|World / Immune cells in Kidney/Urine in Lupus Nephritis | 2.13e-07 | 198 | 94 | 7 | eeec789d226171f30799577cc37c07bdced2e3cb | |
| ToppCell | moderate-Myeloid-Mast_cell|Myeloid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.43e-06 | 166 | 94 | 6 | c3835b424c63bf11a4e2c47635dc3787fc4a637a | |
| ToppCell | 356C-Fibroblasts-Fibroblast-G|356C / Donor, Lineage, Cell class and subclass (all cells) | 2.08e-06 | 177 | 94 | 6 | 8220cc2fc0ee8764a67a3be51d75248be2453040 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-G-|356C / Donor, Lineage, Cell class and subclass (all cells) | 2.08e-06 | 177 | 94 | 6 | 7617270f49cd6b7ba66db72d20560cee985012b2 | |
| ToppCell | facs-Spleen-nan-3m|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.29e-06 | 180 | 94 | 6 | c0c3144011856d005aebd5cdc79f89fee32083a8 | |
| ToppCell | tumor_Lung-Fibroblasts-Undetermined|tumor_Lung / Location, Cell class and cell subclass | 2.37e-06 | 181 | 94 | 6 | 53bcab4d6df4a3255d81877ba22fb95d4492ce9f | |
| ToppCell | saliva-Severe-critical_progression_d12-22_with-steroid-Myeloid-Granulocytic-Neutrophil-Neu_c1-IL1B|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.45e-06 | 182 | 94 | 6 | dc32f8f6a3b13918eb8e93c018f5823d86344080 | |
| ToppCell | Bronchial-10x5prime-Stromal-Fibroblastic-Fibro_myofibroblast|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 4.09e-06 | 199 | 94 | 6 | 21335475bbfbad8a6943b8076a6c1c67f3eec5d3 | |
| ToppCell | cellseq-Mesenchymal-Fibroblastic|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 4.21e-06 | 200 | 94 | 6 | 8978867bf69c830b1e48cac2ad6b512dbe60f149 | |
| ToppCell | Bronchus_Control_(B.)-Stromal-TX-Fibroblasts-2,_SCARA5|Bronchus_Control_(B.) / Sample group, Lineage and Cell type | 4.21e-06 | 200 | 94 | 6 | 2022df85df94ab8cbb4e80e3fe9894c01051c5e0 | |
| ToppCell | distal-2-mesenchymal-Alveolar_Fibroblast|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 4.21e-06 | 200 | 94 | 6 | 12b705dabec1b3752a488a891eda1a5123fcdc41 | |
| ToppCell | normal_Lung-Fibroblasts|normal_Lung / Location, Cell class and cell subclass | 4.21e-06 | 200 | 94 | 6 | 803cf7f1382d07220249029cd220233232027689 | |
| ToppCell | Bronchus_Control_(B.)-Stromal-TX|Bronchus_Control_(B.) / Sample group, Lineage and Cell type | 4.21e-06 | 200 | 94 | 6 | 69b41f5fb370aa8840a9ad7919d03ef1e57d1b5b | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-10w-Neuronal-Neuron|10w / Sample Type, Dataset, Time_group, and Cell type. | 4.21e-06 | 200 | 94 | 6 | 332905a686356cd1e024d40679be98e9d8b1b5e8 | |
| ToppCell | normal_Lung-Fibroblasts-COL14A1+_matrix_FBs|normal_Lung / Location, Cell class and cell subclass | 4.21e-06 | 200 | 94 | 6 | ee3d06865a6300e1279edf6664320b71647f5efb | |
| ToppCell | 356C-Myeloid-Mast_cell|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 2.56e-05 | 164 | 94 | 5 | b3192c443f4848e6a8afdb89c155f9ec42a154b0 | |
| ToppCell | 356C-Myeloid-Mast_cell-|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 2.56e-05 | 164 | 94 | 5 | f7288ec4daf494dae770ea6c58bead27660ccae1 | |
| ToppCell | droplet-Lung-LUNG-30m-Myeloid-plasmacytoid_dendritic_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.87e-05 | 168 | 94 | 5 | e156297a7515e785a9e79a9676700bd3a9d92b98 | |
| ToppCell | droplet-Lung-LUNG-30m-Myeloid-Plasmacytoid_Dendritic|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.87e-05 | 168 | 94 | 5 | 32e0bc0873baa13027241063283ef26d2aab56f5 | |
| ToppCell | LPS-antiTNF-Myeloid-Dendritic_cells-mDC|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.87e-05 | 168 | 94 | 5 | 2dca1c4a33b6da9357fa3b2a523af19baab1c21c | |
| ToppCell | LPS-antiTNF-Myeloid-Dendritic_cells|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.04e-05 | 170 | 94 | 5 | 3cbeea6bfa500928c413b1c6129f6dedc769cd1e | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_B-B_cell-B_c04-SOX5-TNFRSF1B|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.12e-05 | 171 | 94 | 5 | a2938e56cb5749004317798dc7ac0f0c2d4d8ae0 | |
| ToppCell | 368C-Myeloid-Mast_cell|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 3.30e-05 | 173 | 94 | 5 | 8cffb4a37d30b6626188309b868ac4a62e91262f | |
| ToppCell | 368C-Myeloid-Mast_cell-|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 3.30e-05 | 173 | 94 | 5 | fb87ea74bf70aa83b458edf728c81857c8b8eb96 | |
| ToppCell | 10x5'-GI_small-bowel-Mast|GI_small-bowel / Manually curated celltypes from each tissue | 3.39e-05 | 174 | 94 | 5 | e94c980b25edfd0e8598c416828801fcc00e8ead | |
| ToppCell | 10x5'-GI_small-bowel-Mast-Mast_cells|GI_small-bowel / Manually curated celltypes from each tissue | 3.39e-05 | 174 | 94 | 5 | 05525bf0a2bde2be4f7c147b17a24530ce8819e0 | |
| ToppCell | Healthy_Control-Myeloid-Mast|Healthy_Control / Condition, Lineage, Cell class and cell subclass | 3.49e-05 | 175 | 94 | 5 | ca187074adcc9b8bd0fa270e2ede1564c8e6c6cf | |
| ToppCell | Healthy_Control-Myeloid-Mast-|Healthy_Control / Condition, Lineage, Cell class and cell subclass | 3.49e-05 | 175 | 94 | 5 | eadbbcdf2aef4cee268bc70a7a2c4175d898953b | |
| ToppCell | 343B-Fibroblasts-Fibroblast-A_(Fibroblast_progenitors)-|343B / Donor, Lineage, Cell class and subclass (all cells) | 3.58e-05 | 176 | 94 | 5 | 2e94bbe17c0bb65dc58b4ebc0cb829258bd7373b | |
| ToppCell | 343B-Fibroblasts-Fibroblast-A_(Fibroblast_progenitors)|343B / Donor, Lineage, Cell class and subclass (all cells) | 3.58e-05 | 176 | 94 | 5 | f33ab41d121b59d871ad7d48ca021524a027d2ef | |
| ToppCell | 368C-Lymphocytic-NK_cells-NK_cell_E|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 3.68e-05 | 177 | 94 | 5 | 946803293a7955116c80f403e99e4093e798ca3f | |
| ToppCell | 10x3'2.3-week_12-13-Myeloid_DC-DC-pDC|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 3.68e-05 | 177 | 94 | 5 | e36c2005be74ee8ff03c2052504cb496faf86009 | |
| ToppCell | NS-critical-LOC-Epithelial-Ionocyte|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 3.89e-05 | 179 | 94 | 5 | 65a96bee7bc28f5bfc20f0fd92bcc0ab2eb5e06c | |
| ToppCell | facs-Spleen-nan-3m-Lymphocytic|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.99e-05 | 180 | 94 | 5 | 87fb1fdbc49c808bb5f6fe9fb747057b45fa78d0 | |
| ToppCell | severe-Myeloid-Eosinophils|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 3.99e-05 | 180 | 94 | 5 | ac03812b1409435c55d323a7516deeac82bd3509 | |
| ToppCell | critical-Myeloid-Mast_cell|Myeloid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 4.10e-05 | 181 | 94 | 5 | f0d81ae74d3f32979624a94b2ef93774831a7970 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_3|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.20e-05 | 182 | 94 | 5 | 4a9c13932e7163fd37a3dcc4c6ca3bbea5372459 | |
| ToppCell | facs-Kidney-nan-3m|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.20e-05 | 182 | 94 | 5 | 4c5d14e33ebdf117b5aa9e2f57aaa89aa51f72bf | |
| ToppCell | 3'-Broncho-tracheal-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.20e-05 | 182 | 94 | 5 | d179b5deb07c20d49eb6c58d5a65904f8921de3a | |
| ToppCell | droplet-Kidney-nan-21m-Epithelial-Pecam____kidney_capillary_endothelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.32e-05 | 183 | 94 | 5 | f55081068213cc1cdb2acad58ff10f6b48b44c72 | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Epithelial-goblet-Goblet_cell|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.43e-05 | 184 | 94 | 5 | 886d2d9bf2fe31207f17e3edc309ef44029924e1 | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Epithelial-goblet|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.43e-05 | 184 | 94 | 5 | 936b39377eebea3961d702532779f6cd27953be7 | |
| ToppCell | Transplant_Alveoli_and_parenchyma-Immune-Mast_cells|Immune / Tissue, Lineage and Cell class of Lung Cells from 10X | 4.43e-05 | 184 | 94 | 5 | bc394eaa441fcaffcc4ace062741bca1da229324 | |
| ToppCell | control-Myeloid-Eosinophils|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 4.43e-05 | 184 | 94 | 5 | fad517d047e8eaeaa5bd4f311d770880568dd13c | |
| ToppCell | droplet-Spleen-nan-3m-Lymphocytic-plasma_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.54e-05 | 185 | 94 | 5 | ff95a45b7cb782961bb8f008b6b507af2d4cb8b7 | |
| ToppCell | normal_Lung-B_lymphocytes-MALT_B_cells|B_lymphocytes / Location, Cell class and cell subclass | 4.66e-05 | 186 | 94 | 5 | f4d72463c5f287da6436287eda0a349b4185841e | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.66e-05 | 186 | 94 | 5 | 5473283fb95cee556b1f6934cf72169b676b5bcc | |
| ToppCell | systemic_lupus_erythematosus-flare-Hematopoietic-progenitor_cell|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 4.66e-05 | 186 | 94 | 5 | ffd4510b4435d9bf94c2ef14c629f73ab78c5d93 | |
| ToppCell | facs-Spleen-nan-3m-Lymphocytic-CD79a_B_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.78e-05 | 187 | 94 | 5 | b51af2824e65734f333b1325117f4a2e88b17c23 | |
| ToppCell | COVID-19-kidney-Mito-rich_PCT|kidney / Disease (COVID-19 only), tissue and cell type | 4.78e-05 | 187 | 94 | 5 | 738ec2611b4be6a08eedad16b57fba84e1f11fef | |
| ToppCell | systemic_lupus_erythematosus-flare-Hematopoietic-progenitor_cell-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 4.91e-05 | 188 | 94 | 5 | c613c6c7b6de8ed514253c9f9b8622c56fcc1452 | |
| ToppCell | renal_medulla_nuclei|World / Celltypes from Cells and Nuclei per compartment and clinical group | 5.03e-05 | 189 | 94 | 5 | 830d9cd0dd706bce22eb2416f07b2c31c870a05a | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_2_cell-D175|Adult / Lineage, Cell type, age group and donor | 5.16e-05 | 190 | 94 | 5 | 7dcca3469f3a3b70db0420cb94f7765f39492f06 | |
| ToppCell | facs-GAT-Fat-3m|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.16e-05 | 190 | 94 | 5 | 1d92be1b41cff59e834a9d28868f554bd1f3e471 | |
| ToppCell | 10x3'2.3-week_14-16-Endothelial-stroma-immature_EC|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 5.42e-05 | 192 | 94 | 5 | 5af3b2b38495e925497c48f605d618bbf970965d | |
| ToppCell | LPS_only-Stromal_mesenchymal|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.42e-05 | 192 | 94 | 5 | 162d8b5858d150ecbbd1c9bf2b19c6c9cd50a158 | |
| ToppCell | Influenza_Severe-RBC|Influenza_Severe / Disease group and Cell class | 5.42e-05 | 192 | 94 | 5 | f19b6da3fd98da1a76d2570137a8f73a3850ebcb | |
| ToppCell | facs-Aorta-Heart-3m|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.42e-05 | 192 | 94 | 5 | 1ccc47792edf9ee23501c8e2165d11271636b66a | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_2_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 5.56e-05 | 193 | 94 | 5 | 9ab47b360bee1d4f1092c2269e58acebe9584021 | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Epithelial|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.69e-05 | 194 | 94 | 5 | 07d8e38cbc2c7f0564c14f7c365f345f901b73b2 | |
| ToppCell | 10x5'v1-week_12-13-Hematopoietic-MK|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 5.69e-05 | 194 | 94 | 5 | 245a3eb6db9c862b73ad34a8cd2898a3688c16f6 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro1_(4)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 5.69e-05 | 194 | 94 | 5 | 71d3c7448b1734de54187f902f65649f9283bd4c | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 5.69e-05 | 194 | 94 | 5 | 8c37bedb23285735ff3828db3889897fada8c95d | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.83e-05 | 195 | 94 | 5 | df409f94f4e83be89f7a608058ee07ce3ce3a149 | |
| ToppCell | 10x5'v1-week_12-13-Hematopoietic-MK-early_MK|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 5.83e-05 | 195 | 94 | 5 | fa5fc6f605deb5cae96eec14ba4000b19f877ba6 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.83e-05 | 195 | 94 | 5 | 4243190ad291d56694e2155954dbaa879c9d3844 | |
| ToppCell | facs-Lung-3m|Lung / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.83e-05 | 195 | 94 | 5 | c4648c0332c3826776f9ad3f5f803dbac2b4c0c0 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.98e-05 | 196 | 94 | 5 | c7136b1c83bcf907eec3b02b151fa061298b6672 | |
| ToppCell | (7)_MNP-(7)_Macrophage|(7)_MNP / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 5.98e-05 | 196 | 94 | 5 | 71ec157163278ad259c190051926bf41e4ecef46 | |
| ToppCell | (5)_Fibroblasts-(5)_Fibroblast-E|(5)_Fibroblasts / Lung cell shreds - cell class (v4) and cell subclass (v4) | 6.12e-05 | 197 | 94 | 5 | 9b1c1d72c5a8c90d71ae31e4c198d2276872eaa0 | |
| ToppCell | PCW_13-14-Mesenchymal|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 6.12e-05 | 197 | 94 | 5 | 73a2085d2682d636726a5432d572ae2a3fbe1c3f | |
| ToppCell | normal_Lung-Fibroblasts-COL13A1+_matrix_FBs|normal_Lung / Location, Cell class and cell subclass | 6.12e-05 | 197 | 94 | 5 | 6c57ab2efb8363828e24211c4d45e58bb73a9a4d | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.12e-05 | 197 | 94 | 5 | c747c496ac090309b7f8a3e9d840928f12c83f2f | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_1_/_Segment_2|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.12e-05 | 197 | 94 | 5 | 9b038dac4d4d306aa40ec07d79374c4fe9c604a6 | |
| ToppCell | Influenza-Influenza_Severe-Lymphocyte-B-B_intermediate|Influenza_Severe / Disease, condition lineage and cell class | 6.27e-05 | 198 | 94 | 5 | ab622fee61714471af3a7be0af356e8a484dcaff | |
| ToppCell | 3'_v3-GI_small-bowel-Mast-Mast_cells|GI_small-bowel / Manually curated celltypes from each tissue | 6.27e-05 | 198 | 94 | 5 | 920d2e6603a06c2e8dcb6be127202d222c662bca | |
| ToppCell | COVID-19-lung-Fibroblast|COVID-19 / Disease (COVID-19 only), tissue and cell type | 6.27e-05 | 198 | 94 | 5 | 3ec01a55ade5e1627258cc3cfebb2c3207a4cb43 | |
| ToppCell | tumor_Lung-Fibroblasts-COL13A1+_matrix_FBs|tumor_Lung / Location, Cell class and cell subclass | 6.27e-05 | 198 | 94 | 5 | 2d7842f352273b6b823c86eb548b9f4a4cddf0ae | |
| ToppCell | Tracheal-NucSeq-Immune_Myeloid-Mast_cell-Mast_cell|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.27e-05 | 198 | 94 | 5 | cc5ca64749e2f4f1d373d9472824df85741702b7 | |
| ToppCell | Parenchymal-10x5prime-Stromal-Fibroblastic-Fibro_peribronchial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 6.27e-05 | 198 | 94 | 5 | 300d7cc56207d77168390fa1ffcbcf76767b1b80 | |
| ToppCell | Adult-Mesenchymal|Adult / Lineage, Cell type, age group and donor | 6.27e-05 | 198 | 94 | 5 | 26e55b409db2a1637c95fae7c54b0abea1ef550c | |
| ToppCell | Tracheal-10x5prime-Stromal-Fibroblastic-Fibro_myofibroblast|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 6.27e-05 | 198 | 94 | 5 | 7d2fe57e0f9311ac1e6854402ebc154306eb1ba5 | |
| ToppCell | Tracheal-NucSeq-Immune_Myeloid-Mast_cell|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.27e-05 | 198 | 94 | 5 | d4d66f19df078bfc3a83d4664aaf9c7789bde1a5 | |
| ToppCell | COVID-19-lung-Fibroblast|lung / Disease (COVID-19 only), tissue and cell type | 6.27e-05 | 198 | 94 | 5 | df3de77216f5c5d6141ec44d01c56b942f611838 | |
| ToppCell | 3'_v3-GI_small-bowel-Mast|GI_small-bowel / Manually curated celltypes from each tissue | 6.27e-05 | 198 | 94 | 5 | 807e3ed34739eca159dd0970f884b073e588c649 | |
| ToppCell | cellseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 6.27e-05 | 198 | 94 | 5 | f1374f7a50244d59c766ac41f44c08c9117407d2 | |
| ToppCell | (5)_Fibroblast-A_(Fibroblast_progenitors)|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 6.42e-05 | 199 | 94 | 5 | b783917fe0a9725a680aa430a42f02ce294900ef | |
| ToppCell | distal-3-mesenchymal-Adventitial_Fibroblast|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 6.42e-05 | 199 | 94 | 5 | 547a7c30abc730af2670aee00c7a6af60426c9ac | |
| ToppCell | distal-3-mesenchymal-Myofibroblast|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 6.42e-05 | 199 | 94 | 5 | 1f20addc0d138fec02ed6ca4c518169c568de263 | |
| ToppCell | distal-mesenchymal-Adventitial_Fibroblast-3|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 6.42e-05 | 199 | 94 | 5 | 6e8a44e46b46e87b81dbfc56fcbbcde166fd00fe | |
| ToppCell | distal-mesenchymal-Myofibroblast-3|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 6.58e-05 | 200 | 94 | 5 | 069c8949b33ecfdb6da32992002d4060ff6082bc | |
| ToppCell | Bronchial-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.58e-05 | 200 | 94 | 5 | 389cc775c8419d90fb77cd794376d2160a7bf44e | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.58e-05 | 200 | 94 | 5 | ba5ed66b05caa1be0bbf8d54c4e72a782b8d9833 | |
| ToppCell | Transplant_Alveoli_and_parenchyma-Mesenchymal|Transplant_Alveoli_and_parenchyma / Tissue, Lineage and Cell class of Lung Cells from 10X | 6.58e-05 | 200 | 94 | 5 | 954fee8425673e76198be414f5f6c4e3597c1919 | |
| ToppCell | Transplant_Alveoli_and_parenchyma-Mesenchymal-Fibroblasts|Transplant_Alveoli_and_parenchyma / Tissue, Lineage and Cell class of Lung Cells from 10X | 6.58e-05 | 200 | 94 | 5 | bfa73bc5f8a6c7de8353ca049a921ef19f7f4437 | |
| ToppCell | proximal-mesenchymal-Adventitial_Fibroblast|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 6.58e-05 | 200 | 94 | 5 | 58c5870030192b337e7d883044948634fcd17d2c | |
| ToppCell | proximal-mesenchymal-Adventitial_Fibroblast-3|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 6.58e-05 | 200 | 94 | 5 | 05486d86868f6a93429226063cca270f00dd8714 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.58e-05 | 200 | 94 | 5 | 2e4ab7fbd94d3d865ef6188d3b4916d2bf1b8d89 | |
| ToppCell | mild-B_intermediate|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 6.58e-05 | 200 | 94 | 5 | fe815824e9e4be3f3db73610e3814a7fd533da65 | |
| Drug | Piperacillin sodium salt [59703-84-3]; Up 200; 7.4uM; PC3; HT_HG-U133A | 1.54e-06 | 198 | 93 | 8 | 4320_UP | |
| Disease | African Burkitt's lymphoma | 1.39e-05 | 15 | 94 | 3 | C0343640 | |
| Disease | Burkitt Leukemia | 1.39e-05 | 15 | 94 | 3 | C4721444 | |
| Disease | leucine-rich repeat and immunoglobulin-like domain-containing nogo receptor-interacting protein 1 measurement | 3.01e-05 | 3 | 94 | 2 | EFO_0802691 | |
| Disease | MENTAL RETARDATION, AUTOSOMAL DOMINANT 12 | 9.98e-05 | 5 | 94 | 2 | C3281201 | |
| Disease | C-reactive protein measurement | TRERF1 ZSWIM8 LLGL1 LINGO1 CDK2AP1 PAX8 SGCG DTNB NECTIN2 NEURL1 KANK2 BANK1 PPL | 1.16e-04 | 1206 | 94 | 13 | EFO_0004458 |
| Disease | Burkitt Lymphoma | 2.07e-04 | 36 | 94 | 3 | C0006413 | |
| Disease | cholesteryl esters:total lipids ratio, intermediate density lipoprotein measurement | 3.36e-04 | 103 | 94 | 4 | EFO_0008595, EFO_0020944 | |
| Disease | neuroblastoma (is_implicated_in) | 4.44e-04 | 10 | 94 | 2 | DOID:769 (is_implicated_in) | |
| Disease | Neuroblastoma | 4.59e-04 | 47 | 94 | 3 | C0027819 | |
| Disease | Situs Inversus | 5.42e-04 | 11 | 94 | 2 | C0037221 | |
| Disease | cholesteryl esters to total lipids in IDL percentage | 5.51e-04 | 50 | 94 | 3 | EFO_0022247 | |
| Disease | Nonsyndromic Hearing Loss and Deafness, Autosomal Recessive | 5.84e-04 | 51 | 94 | 3 | cv:CN043650 | |
| Disease | cholesterol:total lipids ratio, intermediate density lipoprotein measurement | 6.17e-04 | 121 | 94 | 4 | EFO_0008595, EFO_0020943 | |
| Disease | osteoarthritis | 7.35e-04 | 222 | 94 | 5 | MONDO_0005178 | |
| Disease | Coffin-Siris syndrome | 7.65e-04 | 13 | 94 | 2 | C0265338 | |
| Disease | skin melanoma (is_marker_for) | 7.65e-04 | 13 | 94 | 2 | DOID:8923 (is_marker_for) | |
| Disease | pre-eclampsia (is_marker_for) | 8.51e-04 | 58 | 94 | 3 | DOID:10591 (is_marker_for) | |
| Disease | cholesterol to total lipids in IDL percentage | 9.39e-04 | 60 | 94 | 3 | EFO_0022233 | |
| Disease | Situs ambiguus | 1.03e-03 | 15 | 94 | 2 | C0266642 | |
| Disease | Bladder Neoplasm | 1.06e-03 | 140 | 94 | 4 | C0005695 | |
| Disease | Malignant neoplasm of urinary bladder | 1.09e-03 | 141 | 94 | 4 | C0005684 | |
| Disease | Tetralogy of Fallot | 1.17e-03 | 16 | 94 | 2 | C0039685 | |
| Disease | Alzheimer disease, amyloid-beta measurement | 1.49e-03 | 18 | 94 | 2 | EFO_0005194, MONDO_0004975 | |
| Disease | triglycerides to total lipids in small HDL percentage | 1.59e-03 | 72 | 94 | 3 | EFO_0022336 | |
| Disease | hippocampal tail volume | 1.66e-03 | 19 | 94 | 2 | EFO_0009398 | |
| Disease | Breast Carcinoma | 1.68e-03 | 538 | 94 | 7 | C0678222 | |
| Disease | Nonsyndromic genetic hearing loss | 1.86e-03 | 76 | 94 | 3 | cv:C5680182 | |
| Disease | Colorectal Neoplasms | 1.96e-03 | 277 | 94 | 5 | C0009404 | |
| Disease | periodontitis (biomarker_via_orthology) | 2.03e-03 | 21 | 94 | 2 | DOID:824 (biomarker_via_orthology) | |
| Disease | Nasopharyngeal carcinoma | 2.23e-03 | 22 | 94 | 2 | C2931822 | |
| Disease | Nonsyndromic Deafness | 2.23e-03 | 81 | 94 | 3 | C3711374 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| NMEGSDPAHIAERHG | 376 | Q8NDB2 | |
| DGNPVLLSHHNVMGD | 66 | Q96KX2 | |
| AEHRVPNGMNKGEHA | 176 | Q7Z3E2 | |
| HCNNMHTLGARLPGG | 286 | Q08345 | |
| THLLSMQGSPGGHNR | 126 | Q13227 | |
| MSFDPNLLHNNGHNG | 1 | O75534 | |
| LLPRHELNMAHNAGA | 76 | Q8NFD5 | |
| NGHTPLMEAGSAGHV | 366 | O75179 | |
| HGNNFRIHVSNGLLM | 1146 | Q9H251 | |
| NMASLGGHIISRHPD | 351 | Q06278 | |
| ASLSGHQDRQVPGMA | 221 | P34972 | |
| GVHMVLNHQGRPSGD | 476 | Q6NXG1 | |
| GHAMGLEHSQDPGAL | 406 | P08253 | |
| MPHNSIRSGHGGLNQ | 1 | Q06710 | |
| RDLAQAPDMQGGHAV | 811 | Q15334 | |
| GGAQQRSHHAPMSPG | 351 | O14497 | |
| NGLSPLHMAAQGDHV | 331 | Q01484 | |
| NGNNALHLAVMHGRL | 971 | Q9P2R3 | |
| MAGHPGLSQHLQDGA | 16 | P40424 | |
| NSLHGVDMAANPRAH | 56 | Q00444 | |
| QCHGQGPLAHMPNAS | 176 | P04629 | |
| MGDPHLHGARENIFG | 2096 | Q9UKN7 | |
| ARLAPHMQNAGHPHA | 251 | P53671 | |
| DQFHNMDLRGGPHDG | 46 | Q76N89 | |
| VHVAGRISGAHMNAA | 86 | A0A075B734 | |
| ARAHDGMTPLHAAAQ | 201 | B1AK53 | |
| GEAQLSPQAGRMNHH | 496 | Q9NYF5 | |
| NHAVLRALMHAAAPG | 316 | P27539 | |
| LAAEHPGRNSIEAHM | 281 | O60437 | |
| PGRNSIEAHMEAVHA | 286 | O60437 | |
| GHRHTNAGHRNNMGP | 266 | Q12986 | |
| HGHGDPSFARLGQMV | 166 | P55160 | |
| NAGGNDSMPAHLHVR | 501 | Q96FE5 | |
| MHHHQAPSDGQTPGA | 51 | Q7Z5B4 | |
| VGFMHNAQAGHKQGL | 326 | Q96RP7 | |
| PTMGRHRSNQLFNGH | 396 | P78344 | |
| HRSNQLFNGHGGHIM | 401 | P78344 | |
| RHPHAGNRELMSAAQ | 511 | Q68CR7 | |
| DMGHLTDPQSRDHGF | 86 | O14753 | |
| RMGNGALHGDHQRFS | 221 | Q9BXJ4 | |
| HHNRGPTMQNDGRKE | 581 | Q9ULG6 | |
| HHPGTDNIMALNNAF | 396 | Q8NE35 | |
| HGGGNASRPAESMHE | 321 | Q2WGN9 | |
| NLAAHMPAAALNAAG | 6 | O14519 | |
| AGGPHSNQHQMKEHS | 276 | O60941 | |
| GHQHMVRFLLDSGAN | 146 | Q6ZW76 | |
| SAGHLAHVREQMAGA | 181 | Q63ZY3 | |
| AAGGMGLDLRPHNHL | 131 | Q8IYD2 | |
| LRNPVSMVHAGDGTH | 216 | Q6UWX4 | |
| HGPEALHRQHRGMTE | 31 | Q9ULF5 | |
| SRHQGEHPRMGALDV | 76 | O95954 | |
| LAPADLMEHHSGSQG | 941 | Q15648 | |
| GLLHHMSLQDSGGQS | 46 | P07332 | |
| AGQRPSFSIDHIMGH | 406 | O60548 | |
| SPGMSGHRQGHDSLE | 201 | Q15545 | |
| PAAHHMNNPQRTGQR | 2521 | Q93008 | |
| NHLTLGHNQRMEFLG | 1136 | Q9NRR4 | |
| GPAQRLHMGHGAFLQ | 461 | Q8WUG5 | |
| AAAGSHQLSMGQPHN | 606 | Q68EM7 | |
| AVHAQMHAAVGQLGR | 256 | P29590 | |
| DVNPVMVSGSRGHQH | 386 | O43699 | |
| RERHMPGAAHVVGSQ | 1581 | Q8TF72 | |
| AGALRNPDSGTMNHV | 286 | Q93073 | |
| MGEQNHSPGKELQHR | 1 | Q5H9E4 | |
| MPSRGLANHGQARHM | 601 | Q13330 | |
| LANHGQARHMGPSRN | 606 | Q13330 | |
| LHHAGSAGPDASVMN | 76 | Q9ULL5 | |
| GQHRQGHPENRDMPA | 251 | P49908 | |
| LSMDAPRGVHIQAHA | 201 | Q13326 | |
| EGNTALHLAAGRGHM | 191 | Q495B1 | |
| GGQHARGQHAMQFPA | 101 | Q8IZF4 | |
| GRAPGGASVHNAMQL | 96 | P54922 | |
| ENGHTPLMEAASAGH | 336 | Q8IWZ3 | |
| GNSVLGHLENMHPDN | 2251 | Q8IWZ3 | |
| PDGFSIHHAGMLRQD | 776 | Q8N3C0 | |
| PDLHPAAGHQMNGTN | 136 | Q99967 | |
| LDNPHHGFSNSGIME | 236 | Q5JU69 | |
| ENLQRHMAAHHGDGP | 181 | Q8N8Z8 | |
| NEGDLHGMTPLHLAA | 476 | O75762 | |
| LGHSNEMRLHGVPSE | 266 | Q9H171 | |
| MEGPGLGSQCRNHSH | 1 | Q8IUH4 | |
| DGELHLSHNGAAAGM | 406 | O76050 | |
| GLHDHTQLLRMAGQP | 51 | B1AH88 | |
| SENGLREHMQTHLGP | 941 | Q96K83 | |
| HPGAASGAQTAHRMD | 1726 | Q9H5I5 | |
| SSSMQLPHGGGRHQE | 26 | A6NDX5 | |
| MGPSSLNRHIRDHTG | 111 | Q7L945 | |
| GPGAHLDMNSLDRAQ | 101 | O94826 | |
| EMLGRRAHNDHPNNF | 1676 | A7E2V4 | |
| NHMAREHAFNIGLPD | 191 | Q9NRM2 | |
| SFQRHMIRHTGNGPH | 351 | Q9Y2A4 | |
| MGLHRAQGAPDAPFH | 1371 | Q9H7P9 | |
| CHPGAGAAMARQHAR | 36 | E9PB15 | |
| NTHMPKDRVTGQHQG | 41 | Q15427 | |
| THRGHIFLDGNGMDP | 326 | Q6P4I2 | |
| GMFNVHRHGAINSAA | 331 | O15321 | |
| FKNLPALNGHMRSHG | 521 | Q96PN7 | |
| RSFLMGQGGEAAHHT | 186 | Q96NK8 | |
| PANHQNVAAFHPKMG | 76 | Q92692 |